Crinetics Pharmaceuticals Non-Current Deferred Liabilities (Quarterly) Analysis

Crinetics Pharmaceuticals, Inc. (CRNX)

54.31 -1.04 (-1.88%) USD | NASDAQ | Jan 13, 16:00

55.32 +1.01 (+1.86%) Pre-Market: 20:00

View Non-Current Deferred Liabilities (Quarterly) for CRNX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
GT Biopharma, Inc.	--
Axsome Therapeutics, Inc.	--
Sutro Biopharma, Inc.	Upgrade
Gossamer Bio, Inc.	Upgrade